ReadYourDNA

rs30187 (ERAP1)

What you carry at this position in your DNA and what research says about it.

Ankylosing Spondylitis Risk: 8/10 evidence, 40 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): T/T

Double Risk of Ankylosing Spondylitis

Carrying two copies of the T allele is associated with a twofold increase in the risk of developing ankylosing spondylitis. Conversely, this genotype is linked to slightly lower blood pressure and a reduced risk of hypertension.

What this genotype means: Twofold higher risk of ankylosing spondylitis; Slightly lower blood pressure; Reduced risk of hypertension.

Sample genotype (not yours): C/C

Typical Low Risk of Ankylosing Spondylitis

Carrying two copies of the C allele provides protection against ankylosing spondylitis, maintaining a typical low risk of about 0.1%. However, it is associated with slightly higher blood pressure and hypertension risk.

What this genotype means: Typical low risk (0.1%) of ankylosing spondylitis; Slightly higher blood pressure; Slightly increased risk of hypertension.

Sample genotype (not yours): T/C

Moderately Increased Ankylosing Spondylitis Risk

Carrying one copy of the T allele is linked to a 1.4-fold higher risk of developing ankylosing spondylitis. It also represents an intermediate profile for blood pressure and hypertension risk.

What this genotype means: 1.4x higher risk of ankylosing spondylitis; Intermediate blood pressure levels; Slightly elevated hypertension risk.

About ERAP1

Gene function and biological role

Gene Function: The ERAP1 gene encodes endoplasmic reticulum aminopeptidase 1, an enzyme essential for processing proteins into smaller peptide fragments [1]. These trimmed peptides are then loaded onto major histocompatibility complex class I molecules, which present them on the cell surface to immune cells [1]. This presentation is a critical step in helping the immune system distinguish between the body's own cells and foreign invaders [2]. Beyond its immunological role, ERAP1 also helps regulate blood pressure by degrading angiotensin II, a hormone that constricts blood vessels [3]. Consequently, variations in this gene can influence both autoimmune susceptibility and cardiovascular health.

Variant Impact: A missense mutation in the ERAP1 gene, rs30187 alters the amino acid at position 528 from lysine to arginine [1]. This specific change directly impacts the enzyme's trimming efficiency, altering how effectively it processes peptide antigens [1]. The lysine-encoding T allele produces a highly active enzyme, whereas the arginine-encoding C allele results in reduced trimming activity [4]. This difference in peptide processing alters the repertoire of antigens presented to the immune system, particularly in individuals carrying the HLA-B27 tissue type. Additionally, the altered enzyme activity affects the degradation of vasoactive peptides, thereby influencing blood pressure regulation [3].

Key Insight: This variant acts as a genetic trade-off, where the allele that protects against a severe spinal autoimmune condition slightly increases the risk of high blood pressure.

Location: ERAP1. Chromosome 5 · 5q15 · 96.8 Mb

Genotype Frequencies

Estimated prevalence by population

Global 14.2%; European 11.7%; African 15.6%; East Asian 23.7%; South Asian 17.0%; Americas 16.3%; Ashkenazi 19.2%; Finnish 12.5%; Middle Eastern 24.0%; Amish 30.4%.

Estimated TT genotype frequency.

Global 46.6%; European 45.0%; African 47.8%; East Asian 50.0%; South Asian 48.5%; Americas 48.2%; Ashkenazi 49.2%; Finnish 45.7%; Middle Eastern 50.0%; Amish 49.5%.

Estimated TC genotype frequency.

Global 39.2%; European 43.3%; African 36.5%; East Asian 26.4%; South Asian 34.5%; Americas 35.5%; Ashkenazi 31.5%; Finnish 41.8%; Middle Eastern 26.0%; Amish 20.1%.

Estimated CC genotype frequency.

Associated Traits

Showing effects for T/T genotype

Immunity & Inflammation

Autoimmune Diseases

Ankylosing Spondylitis. Evidence: 8/10. Source: PMID 21743469. 2x Higher Risk.

Cardiovascular & Metabolic

Hypertension

Systolic Blood Pressure. Evidence: 7/10. Source: PMID 33230300. Slightly Lower.

Diastolic Blood Pressure. Evidence: 7/10. Source: PMID 33230300. Slightly Lower.

Hypertension. Evidence: 7/10. Source: PMID 33230300. Reduced Risk.

Blood Cell & Iron Traits

Mean Platelet Volume. Evidence: 7/10. Source: PMID 32888493. Slightly Lower.

Showing effects for C/C genotype

Ankylosing Spondylitis. Evidence: 8/10. Source: PMID 21743469. Typical Low Risk.

Systolic Blood Pressure. Evidence: 7/10. Source: PMID 33230300. Slightly Higher.

Diastolic Blood Pressure. Evidence: 7/10. Source: PMID 33230300. Slightly Higher.

Hypertension. Evidence: 7/10. Source: PMID 33230300. Increased Risk.

Mean Platelet Volume. Evidence: 7/10. Source: PMID 32888493. Slightly Higher.

Showing effects for T/C genotype

Ankylosing Spondylitis. Evidence: 8/10. Source: PMID 21743469. 1.4x Higher Risk.

Systolic Blood Pressure. Evidence: 7/10. Source: PMID 33230300. Intermediate.

Diastolic Blood Pressure. Evidence: 7/10. Source: PMID 33230300. Intermediate.

Hypertension. Evidence: 7/10. Source: PMID 33230300. Slightly Increased.

Mean Platelet Volume. Evidence: 7/10. Source: PMID 32888493. Typical.

What TT Genotype Means

What this genotype means for the people who carry it

Sample genotype: TT (Homozygous)

Susceptibility to ankylosing spondylitis is significantly elevated in individuals carrying two copies of the T allele, particularly when the HLA-B27 gene is also present [1]. This genotype encodes the highly active lysine form of the ERAP1 enzyme, which trims peptides to a length that easily binds to HLA-B27, triggering an autoimmune inflammatory response in the joints. Studies across multiple populations, including Caucasian and East Asian cohorts, consistently replicate this elevated risk. On the cardiovascular side, the highly active enzyme more efficiently degrades angiotensin II, which helps keep blood vessels relaxed [2]. As a result, individuals with this genotype tend to have slightly lower systolic and diastolic blood pressure [2]. They also exhibit a lower overall risk of developing essential hypertension [2]. Despite these cardiovascular benefits, the substantial increase in autoimmune risk makes this genotype unfavorable overall [3].

Twofold higher risk of ankylosing spondylitis; Slightly lower blood pressure; Reduced risk of hypertension.

What CC Genotype Means

Sample genotype: CC (Homozygous)

Protection against the development of ankylosing spondylitis is highly pronounced in individuals with two copies of the C allele, resulting in a typical baseline risk of just 0.1% [1]. This genotype encodes the arginine variant of the ERAP1 enzyme, which has reduced trimming efficiency and fails to generate the specific peptides that trigger spinal joint autoimmunity [2]. Multiple large-scale genetic studies confirm that individuals with this genotype are at a significantly lower risk for inflammatory joint diseases. However, this reduced enzyme activity also means angiotensin II is degraded less efficiently, leaving more of this vessel-constricting hormone in circulation [3]. Consequently, individuals with this genotype experience a small but measurable increase in both systolic and diastolic blood pressure [3]. This translates to a slightly higher susceptibility to essential hypertension over time [3]. Because the autoimmune protection is highly significant, this genotype is considered favorable overall [1].

Typical low risk (0.1%) of ankylosing spondylitis; Slightly higher blood pressure; Slightly increased risk of hypertension.

What TC Genotype Means

Sample genotype: TC (Heterozygous)

Inheriting one T allele and one C allele results in a moderate increase in the risk of ankylosing spondylitis [1]. The presence of the T allele leads to intermediate levels of ERAP1 enzyme activity, which moderately increases the presentation of inflammatory peptides to the immune system [2]. This intermediate activity translates to a 1.4-fold higher likelihood of spinal joint inflammation compared to the baseline population [3]. On the cardiovascular front, this genotype is associated with intermediate blood pressure levels [4]. The balance between the lysine and arginine variants of the enzyme provides moderate degradation of angiotensin II [4]. Consequently, the risk of developing hypertension is only slightly elevated compared to those with the protective cardiovascular genotype [4]. Overall, the moderate increase in autoimmune risk is the primary health factor for carriers [3].

1.4x higher risk of ankylosing spondylitis; Intermediate blood pressure levels; Slightly elevated hypertension risk.

Related Variants

Variants with shared genetic architecture

rs27044 · ERAP1 Gene · Chr 5 · Spondylitis Risk

rs17482078 · ERAP1 Gene · Chr 5 · Inflammatory Disease Risk

rs26653 · ERAP1 Gene · Chr 5 · Autoimmune Joint Risk

Sources

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

Evaluation of ERAP1 gene single nucleotide polymorphisms in immunomodulation of pro-inflammatory and anti-inflammatory cytokines profile in ankylosing spondylitis.

Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals.

Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis.

The association between seven ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis involving 8,530 cases and 12,449 controls.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com